Sohn Jin Hee, Gong Gyungyub, Kim Kyu Rae, Kang Chang Suk, Lee Youn Soo, Kim Jin Man, Jung Woo Hee, Suh Kwang Sun
Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. ; The Cancer Registration Committee of the Korean Society of Pathologists, Seoul, Korea.
Korean J Pathol. 2012 Jun;46(3):226-32. doi: 10.4132/KoreanJPathol.2012.46.3.226. Epub 2012 Jun 22.
Cancer registration in Korea has a longer than 30-years of history, during which time cancer registration has improved and become well-organized. Cancer registries are fundamental for cancer control and multi-center collaborative research. However, there have been discrepancies in assigning behavior codes. Thus, we intend to propose appropriate behavior codes for the International Classification of Disease Oncology, 3rd edition (ICD-O-3) for microinvasive tumors of the ovary and breast not only to improve the quality of the cancer registry but also to prevent conflicts.
As in series I, two pathology study groups and the Cancer Registration Committee of the Korean Society of Pathologists (KSP) participated. To prepare a questionnaire on provisional behavior code, the relevant subjects were discussed in the workshop, and consensus was obtained by convergence of opinion from members of KSP.
Microinvasive tumor of the breast should be designated as a microinvasive carcinoma which was proposed as malignant tumor (/3). Serous borderline tumor with microinvasion of the ovary was proposed as borderline tumor (/1), and mucinous borderline tumor with microinvasion of the ovary as either borderline (/1) or carcinoma (/3) according to the tumor cell nature.
Some issues should be elucidated with the accumulation of more experience and knowledge. Here, however, we present our second proposal.
韩国的癌症登记已有30多年的历史,在此期间癌症登记工作不断改进并变得井井有条。癌症登记是癌症控制和多中心合作研究的基础。然而,在行为代码分配方面存在差异。因此,我们打算为国际疾病分类肿瘤学第3版(ICD-O-3)提出适用于卵巢和乳腺微浸润性肿瘤的行为代码,不仅是为了提高癌症登记的质量,也是为了避免冲突。
与系列I一样,两个病理学研究小组和韩国病理学家协会(KSP)癌症登记委员会参与其中。为准备一份关于临时行为代码的问卷,在研讨会上讨论了相关主题,并通过KSP成员的意见汇聚达成了共识。
乳腺微浸润性肿瘤应指定为微浸润癌,提议将其列为恶性肿瘤(/3)。卵巢伴有微浸润的浆液性交界性肿瘤提议列为交界性肿瘤(/1),卵巢伴有微浸润的黏液性交界性肿瘤根据肿瘤细胞性质列为交界性(/1)或癌(/3)。
随着经验和知识的积累,一些问题应得到阐明。然而,在此我们提出我们的第二项提议。